HB Cold Chain Breaks Into North America’s Core Market

Date:2025-09-26
Pageviews:479

Recently, Haier Biomedical marked another milestone in its globalization journey—its medical cold chain solutions have successfully entered the core application scenarios of the U.S. Department of Veterans Affairs Hospital (VA Hospital) and the University of California, Davis (UC Davis). This is the first time China's high-end medical equipment has been deployed in the core settings of leading U.S. medical and research institutions, marking that Haier Biomedical's "Chinese Solution" has earned recognition in one of the world's most demanding markets, setting a new global benchmark for the globalization of smart healthcare.


2025.9.26.i.jpg


Overcoming High Thresholds: Demonstrating World-Class Strength

The VA Hospital is one of the largest and most rigorous federal medical systems in the United States, with exceptionally high standards for equipment performance, compliance, and service responsiveness. UC Davis and its medical center, as a leading global public research university and medical hub, also hold an outstanding reputation in life sciences and biomedicine.


2025.9.26.2.jpg


Haier Biomedical's successful entry into these two world-class institutions is no coincidence—it represents a rigorous trial and the highest recognition of the core strength of its products, proving that the company's technology, quality, and service have reached the benchmark standards demanded by top-tier medical institutions worldwide.


Smart Cold Chain: Safeguarding the Lifeline of Biosamples


Among the high-end medical cold chain solutions supplied this time, the -30℃ Biomedical Freezer DW-30L818BP stands out as a prime example of Haier Biomedical's world-class technology. Built on cutting-edge technological advantages in reliability, precision, and intelligence, it establishes a defense line for valuable biosamples, vaccines, and reagents, providing strong support for the precise advancement of cutting-edge medical research and clinical diagnosis and treatment.


2025.9.26.3.jpg


Global Empowerment: From "Made in China" to "Global Healthcare Infrastructure Core Partner"


Through efficient localized operations and service collaboration, Haier Biomedical has forged direct access to the core users of top U.S. medical and research institutions, writing a powerful new chapter in its globalization journey. This not only demonstrates Haier Biomedical’s profound technological foundation and strong ecosystem integration capabilities, but also proves that China's smart healthcare has reached a new height in the global high-end market.

Choosing Haier Biomedical means laying a solid foundation for life sciences research and healthcare protection, while jointly ushering in a new era of safer, more efficient, and smarter future for the medical and health industry.